{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T20:00:48Z","timestamp":1700596848341},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Due to widespread anti-malarial drug resistance in many countries, Kenya included, artemisinin-based Combination Therapy (ACT) has been adopted as the most effective treatment option against malaria. Artemether-lumefantrine (AL) is the first-line ACT for treatment of uncomplicated malaria in Kenya, while quinine is preferred for complicated and severe malaria. Information on the providers\u2019 knowledge and practices prior to or during AL and quinine implementation is scanty. The current study evaluated providers\u2019 knowledge and practices of treatment policy and dosing regimens with AL and quinine in the public, private and not-for-profit drug outlets.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A cross-sectional survey using three-stage sampling of 288 (126 public, 96 private and 66 not-for-profits) providers in drug outlets was conducted in western Kenya in two <jats:italic>Plasmodium falciparum<\/jats:italic>-endemic regions with varying malarial risk. Information on provider in-service training, knowledge (qualification, treatment policy, dosing regimen, recently banned anti-malarials) and on practices (request for written prescription, prescription of AL, selling partial packs and advice given to patients after prescription), was collected.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Only 15.6% of providers in private outlets had received any in-service training on AL use. All (100%) in public and majority (98.4%) in not-for-profit outlets mentioned AL as first line-treatment drug. Quinine was mentioned as second-line drug by 47.9% in private outlets. A total of 92.0% in public, 57.3% in private and 78.8% in not-for-profit outlets stated correct AL dose for adults. A total of 85.7% of providers in public, 30.2% in private and 41.0% in not-for-profit outlets were aware that SP recommendations changed from treatment for mild malaria to IPTp in high risk areas. In-service training influenced treatment regimen for uncomplicated malaria (<jats:italic>P<\/jats:italic>\u2009=\u20090.039 and <jats:italic>P<\/jats:italic>\u2009=\u20090.039) and severe malaria (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001 and <jats:italic>P<\/jats:italic>\u2009=\u20090.002) in children and adults, respectively. Most (82.3%) of private outlets sell partial packs of AL while 72.4% do not request for written prescription for AL. In-service training influenced request for written prescription (<jats:italic>P<\/jats:italic>\u2009=\u20090.001), AL prescription (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001) and selling of partial packs (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Public-sector providers have higher knowledge on treatment policy and dosing regimen on recommended anti-malarials. Changes in treatment guidelines should be accompanied by subsequent implementation activities involving all sector players in unbiased strategies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1475-2875-11-436","type":"journal-article","created":{"date-parts":[[2012,12,29]],"date-time":"2012-12-29T07:26:45Z","timestamp":1356766005000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Provider knowledge of treatment policy and dosing regimen with artemether-lumefantrine and quinine in malaria-endemic areas of western Kenya"],"prefix":"10.1186","volume":"11","author":[{"given":"Carren A","family":"Watsierah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosebella O","family":"Onyango","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James H","family":"Ombaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benard O","family":"Abong\u2019o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Collins","family":"Ouma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,29]]},"reference":[{"key":"2588_CR1","volume-title":"The world health report 2002: reducing risks, promoting healthy life","author":"WHO","year":"2002","unstructured":"WHO: The world health report 2002: reducing risks, promoting healthy life. 2002, Geneva: World Health Organization"},{"key":"2588_CR2","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4269\/ajtmh.2004.71.196","volume":"71","author":"PG Coleman","year":"2004","unstructured":"Coleman PG, Morel C, Shillcutt S, Goodman C, Mills AJ: A threshold analysis of the cost-effectiveness of artemisinin-based combination therapies in sub-saharan Africa. Am JTrop Med Hyg. 2004, 71: 196-204.","journal-title":"Am JTrop Med Hyg"},{"key":"2588_CR3","volume-title":"The use of anti-malarials. Report of WHO informal consultations 13\u201317, November 2000","author":"WHO","year":"2000","unstructured":"WHO: The use of anti-malarials. Report of WHO informal consultations 13\u201317, November 2000. 2000, Geneva: World Health Organization"},{"key":"2588_CR4","volume-title":"National malaria treatment guidelines","author":"MoH","year":"2006","unstructured":"MoH: National malaria treatment guidelines. 2006, Kenya: Nairobi Kenya: Ministry of Health"},{"key":"2588_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1475-2875-6-57","volume":"6","author":"TO Abuya","year":"2007","unstructured":"Abuya TO, Mutemi W, Karisa B, Ochola SA, Fegan G, Marsh V: Use of over-the-counter malaria medicines in children and adults in three districts in Kenya: Implications for private medicine retailer interventions. Malar J. 2007, 6: 57-10.1186\/1475-2875-6-57.","journal-title":"Malar J"},{"key":"2588_CR6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/1475-2875-9-295","volume":"9","author":"CA Watsierah","year":"2010","unstructured":"Watsierah CA, Jura WG, Oyugi H, Abong\u2019o B, Ouma C: Factors determining anti-malaria drug use in a peri-urban population from malaria holoendemic region of western Kenya. Malar J. 2010, 9: 295-10.1186\/1475-2875-9-295.","journal-title":"Malar J"},{"key":"2588_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2147\/RMHP.S23054","volume":"4","author":"V Mugoyela","year":"2011","unstructured":"Mugoyela V, Minzi O: Implementation of artemether-lumefantrine treatment policy for malaria at health facilities in Tanzania. Risk Manag Healthc Policy. 2011, 4: 89-95.","journal-title":"Risk Manag Healthc Policy"},{"key":"2588_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4314\/eamj.v85i5.9615","volume":"85","author":"J Njogu","year":"2008","unstructured":"Njogu J, Akhwale W, Hamer DH, Zurovac D: Health facility and health worker readiness to deliver new national treatment policy for malaria in Kenya. East Afr Med J. 2008, 85: 213-221.","journal-title":"East Afr Med J"},{"key":"2588_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2875-10-1","volume":"10","author":"E Juma","year":"2011","unstructured":"Juma E, Zurovac D: Changes in health workers\u2019 malaria diagnosis and treatment practices in Kenya. Malar J. 2011, 10: 1-10.1186\/1475-2875-10-1.","journal-title":"Malar J"},{"key":"2588_CR10","doi-asserted-by":"publisher","first-page":"e24781","DOI":"10.1371\/journal.pone.0024781","volume":"6","author":"A Nyandigisi","year":"2011","unstructured":"Nyandigisi A, Memusi D, Mbithi A, Ang\u2019wa N, Shieshia M, Muturi A, Sudoi R, Githinji S, Juma E, Zurovac D: Malaria case-management following change of policy to universal parasitological diagnosis and targeted artemisinin-based combination therapy in Kenya. PLoS One. 2011, 6: e24781-10.1371\/journal.pone.0024781.","journal-title":"PLoS One"},{"key":"2588_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1475-2875-7-29","volume":"7","author":"B Wasunna","year":"2008","unstructured":"Wasunna B, Zurovac D, Goodman CA, Snow RW: Why don\u2019t health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine. Malar J. 2008, 7: 29-10.1186\/1475-2875-7-29.","journal-title":"Malar J"},{"key":"2588_CR12","volume-title":"Malaria in Kenya at a glance","author":"Kenya Malaria Fact Sheet","year":"2011","unstructured":"Kenya Malaria Fact Sheet: Malaria in Kenya at a glance. 2011, Kenya, http:\/\/www.kemri.org,"},{"key":"2588_CR13","unstructured":"List of Public health facilities in Kenya. 2011, Kenya, http:\/\/www.ehealth.or.ke\/facilities-3\/5\/2011,"},{"key":"2588_CR14","volume-title":"Measuring medicine prices, availability, affordability and price components","author":"WHO","year":"2008","unstructured":"WHO: Measuring medicine prices, availability, affordability and price components. 2008, Geneva: World Health Organization"},{"key":"2588_CR15","volume-title":"National malaria strategies 2009\u20132017","author":"MoPHS","year":"2009","unstructured":"MoPHS: National malaria strategies 2009\u20132017. 2009, Nairobi, Kenya: Ministry of Public Health and Sanitation, Division of Malaria Control"},{"key":"2588_CR16","volume-title":"National guidelines for diagnosis, treatment and prevention of malaria for health workers","author":"MoPHS","year":"2010","unstructured":"MoPHS: National guidelines for diagnosis, treatment and prevention of malaria for health workers. 2010, Nairobi, Kenya: Ministry of Public Health and Sanitation, Division of Malaria Control"},{"key":"2588_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1475-2875-6-72","volume":"6","author":"AA Amin","year":"2007","unstructured":"Amin AA, Zurovac D, Kangwana BB, Greenfield J, Otieno DN, Akhwale W, Snow RW: The challenges of changing national malaria drug policy to artemisinin-based combination in Kenya. Malar J. 2007, 6: 72-10.1186\/1475-2875-6-72.","journal-title":"Malar J"},{"key":"2588_CR18","volume-title":"Kenya malaria monitoring and evaluation plan-2009-2017","author":"MoPHS","year":"2009","unstructured":"MoPHS: Kenya malaria monitoring and evaluation plan-2009-2017. 2009, Nairobi, Kenya: Ministry of Public Health and Sanitation, Division of Malaria Control"},{"key":"2588_CR19","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0277-9536(00)00142-8","volume":"52","author":"B Stensen","year":"2001","unstructured":"Stensen B, Syhakhang L, Ericksson B: Real world pharmacy: assessing the quality of private pharmacy practice in Lao People\u2019s Democratic Republic. Soc Sci Med. 2001, 52: 393-404. 10.1016\/S0277-9536(00)00142-8.","journal-title":"Soc Sci Med"},{"key":"2588_CR20","first-page":"390","volume":"73","author":"DN Ongore","year":"1996","unstructured":"Ongore DN, Nyabola L: Role of shops and shopkeepers in malaria control. East Afr Med J. 1996, 73: 390-394.","journal-title":"East Afr Med J"},{"key":"2588_CR21","first-page":"13","volume-title":"The role of pharmacists in healthcare system. Report of consultative Group","author":"WHO","year":"1988","unstructured":"WHO: The role of pharmacists in healthcare system. Report of consultative Group. 1988, Geneva: Action programme on essential medicines and unit of pharmaceuticals, 13-16."},{"key":"2588_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1475-2875-10-99","volume":"10","author":"CA Watsierah","year":"2011","unstructured":"Watsierah CA, Jura WGZO, Raballah E, Kaseje D, Abong\u2019o B, Ouma C: Knowledge and behaviour as determinants of anti-malarial drug use in peri-urban population from malaria holoendemic region of western Kenya. Malar J. 2011, 10: 99-10.1186\/1475-2875-10-99.","journal-title":"Malar J"},{"key":"2588_CR23","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/j.1365-3156.2008.02072.x","volume":"13","author":"D Zurovac","year":"2008","unstructured":"Zurovac D, Njogu J, Akhwale W, Hamer DH, Larson BA, Snow RW: Effects of revised diagnostic recommendations on malaria treatment practices across age groups in Kenya. Trop Med Int Health. 2008, 13: 784-787. 10.1111\/j.1365-3156.2008.02072.x.","journal-title":"Trop Med Int Health"},{"key":"2588_CR24","first-page":"117","volume":"5","author":"OM Minzi","year":"2008","unstructured":"Minzi OM, Haule AF: Poor knowledge on new malaria treatment guidelines among drug dispensers in private pharmacies in Tanzania: The need for involving the private sector in policy preparations. East Afr J Public Health. 2008, 5: 117-121.","journal-title":"East Afr J Public Health"},{"key":"2588_CR25","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1365-3156.2007.01820.x","volume":"12","author":"M Mayxay","year":"2007","unstructured":"Mayxay M, Pongvongsa T, Phompida S, Phetsouvanh R, White NJ, Newton PN: Diagnosis and management of malaria by rural community health providers in the Lao People\u2019s Democratic Republic (Laos). Trop Med Int Health. 2007, 12: 540-546. 10.1111\/j.1365-3156.2007.01820.x.","journal-title":"Trop Med Int Health"},{"key":"2588_CR26","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1046\/j.1365-3156.1999.00403.x","volume":"4","author":"VM Marsh","year":"1999","unstructured":"Marsh VM, Mutemi WM, Muturi J, Haaland A, Watkins WM, Otieno G, Marsh K: Changing home treatment of childhood fevers by training shop keepers in rural Kenya. Trop Med Int Health. 1999, 4: 383-389. 10.1046\/j.1365-3156.1999.00403.x.","journal-title":"Trop Med Int Health"},{"key":"2588_CR27","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1365-3156.2004.01223.x","volume":"9","author":"VM Marsh","year":"2004","unstructured":"Marsh VM, Mutemi WM, Willetts A, Bayah K, Were S, Ross A, Marsh K: Improving malaria home treatment by training drug retailers in rural Kenya. Trop Med Int Health. 2004, 9: 451-460. 10.1111\/j.1365-3156.2004.01223.x.","journal-title":"Trop Med Int Health"},{"key":"2588_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1365-3156.2007.01980.x","volume":"13","author":"D Zurovac","year":"2008","unstructured":"Zurovac D, Njogu J, Akhwale W, Hamer DH, Snow RW: Translation of artemether-lumefantrine treatment policy into paediatric clinical practice: An early experiecne from Kenya. Trop Med Int Health. 2008, 13: 99-107. 10.1111\/j.1365-3156.2007.01980.x.","journal-title":"Trop Med Int Health"},{"key":"2588_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1475-2875-2-10","volume":"2","author":"P Tavrow","year":"2003","unstructured":"Tavrow P, Shabahang J, Makama S: Vendor-to-vendor education to improve malaria treatment by private drug outlets in Bungoma District. Kenya. Malar J. 2003, 2: 10-10.1186\/1475-2875-2-10.","journal-title":"Malar J"},{"key":"2588_CR30","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/004947558601600218","volume":"16","author":"M.V. VRJVR-W","year":"1986","unstructured":"M.V. VRJVR-W: Effectiveness of seminars in training rural health workers. Trop Doct. 1986, 16: 90-92.","journal-title":"Trop Doct"},{"key":"2588_CR31","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/j.1365-3156.2005.01486.x","volume":"10","author":"J Eriksen","year":"2005","unstructured":"Eriksen J, Nsimba SE, Minzi OM: Adoption of new antimalarial drug policy in Tanzania- a cross-sectional study in the community. Trop Med Int Health. 2005, 10: 1038-1046. 10.1111\/j.1365-3156.2005.01486.x.","journal-title":"Trop Med Int Health"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-11-436.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T21:31:09Z","timestamp":1630531869000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/1475-2875-11-436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2588"],"URL":"https:\/\/doi.org\/10.1186\/1475-2875-11-436","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"23 August 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"436"}}